.svg)
.webp)
Multi-Product Success with 60% Closed-One Rate and $2.6M Unlocked
The Challenge
Selling to scientists is difficult enough. Selling three different products to different scientific audiences compounds that difficulty significantly.
Molecular devices, a leading danaher company in biotech automation, faced three distinct business challenges:
1. Generating fresh interest for established products in markets where many labs already owned similar equipment
2. Introducing new products to existing customers who knew them for something else
3. Efficiently connecting with very specific prospects in specialised labs
The Solution
We used our Priority ABX™ tech to launch one clear ABM strategy across all product types.
For mature products, we found and ranked the best-fit accounts, built a solid ABM setup, and ran campaigns across channels like email, ads, and video. We tracked results closely and used personalised outreach to boost engagement.
For new products, we used ABX data to spot key decision-makers in current accounts, wrote targeted messages, and created custom content. Then we reached out through trusted contacts and kept fast feedback between sales and marketing.
For regulated products, we focused on senior scientists in small biotech and pharma companies. We built sharp, targeted campaigns and kept improving our message based on what was working.
Simple, focused, and driven by data.
Results
The program delivered strong results across every product line. For mature products, it generated a 112% increase in pipeline and exceeded new opportunity creation goals by 300%. Outreach for new products successfully engaged 300 accounts and delivered three times the expected number of new opportunities. Regulatory campaigns achieved 66% engagement with hard-to-reach scientists and sparked 269 new account conversations. Overall, the strategy engaged 90% of target accounts and delivered a 3.4x lift in opportunity creation for regulatory-focused efforts.
Other Stories
Positioning WJ UK for a multi million opportunity
Discover how strategic outreach helped WJ UK break into the £96B AMP8 market. This case study reveals how we booked 94 meetings with the right decision-makers.
$41M in Pipeline Unlocked for Ephesus
Discover how we helped Ephesus break through long sales cycles and tough-to-reach stakeholders—achieving $41M in qualified deals, and 75% larger deal sizes using a smarter, ABX-driven outreach strategy.
Multi-Product Success with 60% Closed-One Rate and $2.6M Unlocked
See how a unified ABM approach helped this team exceed pipeline targets by 189% and generate millions in revenue—while driving a 60% win rate with key decision-makers.
Your complete revenue team for pipeline growth & faster closing
Average ROI
Total pipeline generated
Meetings booked per year
Multi-Product Success with 60% Closed-One Rate and $2.6M Unlocked
Brief and results
The Challenge
Selling to scientists is difficult enough. Selling three different products to different scientific audiences compounds that difficulty significantly.
Molecular devices, a leading danaher company in biotech automation, faced three distinct business challenges:
1. Generating fresh interest for established products in markets where many labs already owned similar equipment
2. Introducing new products to existing customers who knew them for something else
3. Efficiently connecting with very specific prospects in specialised labs
The Solution
We used our Priority ABX™ tech to launch one clear ABM strategy across all product types.
For mature products, we found and ranked the best-fit accounts, built a solid ABM setup, and ran campaigns across channels like email, ads, and video. We tracked results closely and used personalised outreach to boost engagement.
For new products, we used ABX data to spot key decision-makers in current accounts, wrote targeted messages, and created custom content. Then we reached out through trusted contacts and kept fast feedback between sales and marketing.
For regulated products, we focused on senior scientists in small biotech and pharma companies. We built sharp, targeted campaigns and kept improving our message based on what was working.
Simple, focused, and driven by data.
Results
The program delivered strong results across every product line. For mature products, it generated a 112% increase in pipeline and exceeded new opportunity creation goals by 300%. Outreach for new products successfully engaged 300 accounts and delivered three times the expected number of new opportunities. Regulatory campaigns achieved 66% engagement with hard-to-reach scientists and sparked 269 new account conversations. Overall, the strategy engaged 90% of target accounts and delivered a 3.4x lift in opportunity creation for regulatory-focused efforts.
